Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible light Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119930443A details a visible light photocatalytic method for trifluoromethylation. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115838330B reveals a visible-light method for dicarboxylic acids using CO2. This breakthrough offers cost reduction and supply chain reliability for fine chemical manufacturing.
Novel visible light method synthesizes 3-sulfonyl spirocyclic trienones using air oxidant. Reduces energy and metal waste for reliable pharmaceutical intermediate supply chains.
Patent CN113444005B details a green visible-light method for synthesizing glutaric acids from olefins and CO2, offering significant supply chain and cost advantages.
Novel photocatalytic route for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light. Offers mild conditions and broad substrate scope for pharma applications.
Patent CN103910723A reveals a novel visible light catalytic method for indoloquinoline synthesis using cheap metal salts and air oxygen, offering significant cost and supply chain advantages.
Patent CN113603653A reveals a visible light-promoted method for seleno-oxazolidine-2,4-dione. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel visible-light method replaces expensive silver reagents, offering high-yield, scalable production for pharmaceutical intermediates.
Patent CN106831603B reveals metal-free visible light synthesis for fluoropyrimidines, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN112142796A details a mild synthesis of isoquinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel green synthesis method for alpha-bromo-aromatic ketones using Ru(bpy)3Cl2 photocatalyst, offering high selectivity and mild conditions for pharmaceutical intermediates.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.
Novel visible light catalysis method for indol-3-one derivatives. Offers mild conditions and high yield for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Patent CN115745822A enables green visible light synthesis of N-formyl amides using copper catalysis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.